01 1Cadila Pharmaceuticals
01 1NEBIVOLOL HYDROCHLORIDE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-03-25
Pay. Date : 2013-09-11
DMF Number : 21152
Submission : 2007-12-08
Status : Active
Type : II
20
Cadila Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NEBIVOLOL HYDROCHLORIDE, with a corresponding US DMF Number 21152.
Remarkably, this DMF maintains an Active status since its submission on December 08, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 25, 2014, and payment made on September 11, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
